Cargando…

Multiple drugs: COVID-19 pneumonia: 4 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954690/ http://dx.doi.org/10.1007/s40278-021-92459-6

Ejemplares similares

Multiple drugs: COVID-19 and COVID-19 pneumonia: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia and compassionate use of clazakizumab for COVID-19 pneumonia: case report
Publicado: (2020)

Multiple drugs: COVID-19 and Streptococcus pneumoniae infection: case report
Publicado: (2022)

Multiple drugs: COVID-19 pneumonia and lack of efficacy: 3 case reports
Publicado: (2022)

Multiple drugs: COVID-19: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19-pneumonia and increase in drug levels due to interactions: 2 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection: 4 case reports
Publicado: (2020)

Multiple drugs: Lack of efficacy in COVID-19 pneumonia and off label use: case report
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia, off-label use and lack of efficacy: case report
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia, Pneumocystis jirovecii and Aspergillus fumigatus infection: case report
Publicado: (2020)

Multiple drugs: COVID-19 pneumonia secondary to hypogammaglobulinaemia and off-label use: case report
Publicado: (2022)

Multiple drugs: Neutropenia and COVID-19 infection: 4 case reports
Publicado: (2020)

Multiple drugs: COVID-19-pneumonia, off-label use and lack of efficacy: 2 case reports
Publicado: (2021)

Multiple drugs: Drug-induced pneumonia, Legionella pneumophila pneumonia and lack of efficacy: case report
Publicado: (2021)

Multiple drugs: COVID-19: case report
Publicado: (2021)

Multiple drugs: Pneumonitis and Pneumocystis jirovecii pneumonia: case report
Publicado: (2021)

Multiple drugs: COVID-19 prolongation: case report
Publicado: (2021)

Multiple drugs: Pneumocystis jiroveci pneumonia, hospital acquired pneumonia and lack of efficacy: case report
Publicado: (2021)

Rituximab: Relapse or exacerbation of COVID-19 pneumonia: 4 case reports
Publicado: (2022)

Multiple drugs: Protracted severe COVID-19 pneumonia, hepatotoxicity and lack of efficacy following off label use: case report
Publicado: (2022)

Multiple drugs: COVID-19 infection: 15 case reports
Publicado: (2021)

Multiple drugs: Covid-19 reinfection: 2 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection: 6 case reports
Publicado: (2021)

Multiple drugs: Lymphopaenia and COVID-19 infection: case report
Publicado: (2020)

Multiple drugs: COVID‑19 infection: 6 case report
Publicado: (2022)

Multiple drugs: COVID-19 infection: 5 case reports
Publicado: (2022)

Multiple drugs: Pneumocystis jirovecii pneumonia and allergic rash: 3 case reports
Publicado: (2022)

Multiple drugs: Lethal COVID-19 and lack of efficacy: case report
Publicado: (2021)

Multiple drugs: Prolonged COVID-19 viral shedding: case report
Publicado: (2021)

Multiple drugs: COVID-19 and impaired humoral immunity: case report
Publicado: (2021)

Incidental finding of mild COVID-19 pneumonia with multiple thromboembolic disease: A case report
por: Yusuf Mohamud, Mohamed Farah, et al.
Publicado: (2022)

Immunosuppressants: COVID-19 pneumonia: case report
Publicado: (2021)

Dasatinib: COVID-19 pneumonia: case report
Publicado: (2021)

Prednisolone: COVID-19 pneumonia: case report
Publicado: (2020)

Infliximab: COVID-19 pneumonia: case report
Publicado: (2020)

Dexamethasone: COVID-19-pneumonia: case report
Publicado: (2022)

Immunosuppressants: COVID-19 and COVID-19-pneumonia: 19 case reports
Publicado: (2021)

Multiple drugs: COVID-19 reinfection, COVID-19 reactivation and differentiation syndrome: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy: 4 case reports
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7cq6t8embcluibptd6fd07ckma